Medical Grade Chitosan - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Medical Grade Chitosan - Global Top Players Market Share and Ranking 2025

Medical Grade Chitosan - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-10-30
Report Id: 2630851
Industry: Pharma & Healthcare
Report Page: 115
Chart: 117

PDF Download

Publication Date: 2025-10-30
Report Id: 2630851
Industry: Pharma & Healthcare
Report Page: 115
Chart: 117

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Medical Grade Chitosan Definition
1.2 Global Medical Grade Chitosan Market Size and Forecast
1.2.1 By Consumption Value, Global Medical Grade Chitosan Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Medical Grade Chitosan Market Size, 2020-2031
1.2.3 Global Medical Grade Chitosan Average Selling Price (ASP), 2020-2031
1.3 China Medical Grade Chitosan Market Size and Forecast
1.3.1 By Consumption Value, China Medical Grade Chitosan Market Size, 2020-2031
1.3.2 By Sales Quantity, China Medical Grade Chitosan Market Size, 2020-2031
1.3.3 China Medical Grade Chitosan Average Selling Price (ASP), 2020-2031
1.4 Share of China Medical Grade Chitosan Market with Respect to the Global Market
1.4.1 By Consumption Value, China Medical Grade Chitosan Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Medical Grade Chitosan Market Share in Global, 2020-2031
1.4.3 Medical Grade Chitosan Market Size: China VS Global, 2020-2031
1.5 Medical Grade Chitosan Market Dynamics
1.5.1 Medical Grade Chitosan Market Drivers
1.5.2 Medical Grade Chitosan Market Restraints
1.5.3 Medical Grade Chitosan Industry Trends
1.5.4 Medical Grade Chitosan Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Medical Grade Chitosan, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Medical Grade Chitosan, Global Market Share by Company, 2020-2025
2.3 Medical Grade Chitosan Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Medical Grade Chitosan Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Medical Grade Chitosan Concentration Ratio
2.6 Global Medical Grade Chitosan Mergers & Acquisitions, Expansion Plans
2.7 Global Medical Grade Chitosan Manufacturers Product Type
2.8 Head Office and Medical Grade Chitosan Production Site of Key Manufacturer
2.9 Medical Grade Chitosan Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Medical Grade Chitosan, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Medical Grade Chitosan, China Market Share by Company, 2020-2025
3.3 China Medical Grade Chitosan Medical Grade Chitosan Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Medical Grade Chitosan Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Medical Grade Chitosan Capacity by Region
4.3 Global Medical Grade Chitosan Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Medical Grade Chitosan Production by Region, 2020-2031
4.5 Global Medical Grade Chitosan Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Medical Grade Chitosan Industry Chain
5.2 Medical Grade Chitosan Upstream Analysis
5.2.1 Medical Grade Chitosan Core Raw Materials
5.2.2 Main Manufacturers of Medical Grade Chitosan Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medical Grade Chitosan Production Mode
5.6 Medical Grade Chitosan Procurement Model
5.7 Medical Grade Chitosan Industry Sales Model and Sales Channels
5.7.1 Medical Grade Chitosan Sales Model
5.7.2 Medical Grade Chitosan Typical Distributors

6 Sights by Source
6.1 Medical Grade Chitosan Classification by Source
6.1.1 Marine (Crustacean-derived)
6.1.2 Fungal (Non-animal)
6.2 by Source, Global Medical Grade Chitosan Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Source, Global Medical Grade Chitosan Consumption Value, 2020-2031
6.4 by Source, Global Medical Grade Chitosan Sales Quantity, 2020-2031
6.5 by Source, Global Medical Grade Chitosan Average Selling Price (ASP), 2020-2031

7 Sights by Form
7.1 Medical Grade Chitosan Classification by Form
7.1.1 Powder/Flake
7.1.2 Salts & Derivatives
7.2 by Form, Global Medical Grade Chitosan Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Form, Global Medical Grade Chitosan Consumption Value, 2020-2031
7.4 by Form, Global Medical Grade Chitosan Sales Quantity, 2020-2031
7.5 by Form, Global Medical Grade Chitosan Average Selling Price (ASP), 2020-2031

8 Sights by Channel
8.1 Medical Grade Chitosan Classification by Channel
8.1.1 Direct Sale
8.1.2 Indirect Sale
8.2 by Channel, Global Medical Grade Chitosan Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Channel, Global Medical Grade Chitosan Consumption Value, 2020-2031
8.4 by Channel, Global Medical Grade Chitosan Sales Quantity, 2020-2031
8.5 by Channel, Global Medical Grade Chitosan Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Medical Grade Chitosan Segment by Application
9.1.1 Wound Care & Exudate Management
9.1.2 Hemostats & Emergency Care
9.1.3 Pharma Excipients & Drug Delivery
9.1.4 Tissue Engineering & Regenerative Medicine
9.1.5 Medical Cosmetology
9.1.6 Other Medical Uses
9.2 by Application, Global Medical Grade Chitosan Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Medical Grade Chitosan Consumption Value, 2020-2031
9.4 by Application, Global Medical Grade Chitosan Sales Quantity, 2020-2031
9.5 by Application, Global Medical Grade Chitosan Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Medical Grade Chitosan Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Medical Grade Chitosan Consumption Value, 2020-2031
10.3 By Region, Global Medical Grade Chitosan Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Medical Grade Chitosan Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Medical Grade Chitosan Market Size Market Share
10.5 Europe
10.5.1 Europe Medical Grade Chitosan Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Medical Grade Chitosan Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Medical Grade Chitosan Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Medical Grade Chitosan Market Size Market Share
10.7 South America
10.7.1 South America Medical Grade Chitosan Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Medical Grade Chitosan Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Medical Grade Chitosan Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Medical Grade Chitosan Consumption Value, 2020-2031
11.3 By Country, Global Medical Grade Chitosan Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Medical Grade Chitosan Market Size, 2020-2031
11.4.2 by Source, United States Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Medical Grade Chitosan Market Size, 2020-2031
11.5.2 by Source, Europe Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Medical Grade Chitosan Market Size, 2020-2031
11.6.2 by Source, China Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Medical Grade Chitosan Market Size, 2020-2031
11.7.2 by Source, Japan Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Medical Grade Chitosan Market Size, 2020-2031
11.8.2 by Source, South Korea Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Medical Grade Chitosan Market Size, 2020-2031
11.9.2 by Source, Southeast Asia Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Medical Grade Chitosan Market Size, 2020-2031
11.10.2 by Source, India Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Medical Grade Chitosan Market Size, 2020-2031
11.11.2 by Source, Middle East & Africa Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Medical Grade Chitosan Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Primex
12.1.1 Primex Company Information, Head Office, Market Area, and Industry Position
12.1.2 Primex Medical Grade Chitosan Models, Specifications, and Application
12.1.3 Primex Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Primex Company Profile and Main Business
12.1.5 Primex Recent Developments
12.2 KitoZyme
12.2.1 KitoZyme Company Information, Head Office, Market Area, and Industry Position
12.2.2 KitoZyme Medical Grade Chitosan Models, Specifications, and Application
12.2.3 KitoZyme Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 KitoZyme Company Profile and Main Business
12.2.5 KitoZyme Recent Developments
12.3 BIO21
12.3.1 BIO21 Company Information, Head Office, Market Area, and Industry Position
12.3.2 BIO21 Medical Grade Chitosan Models, Specifications, and Application
12.3.3 BIO21 Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 BIO21 Company Profile and Main Business
12.3.5 BIO21 Recent Developments
12.4 YSK
12.4.1 YSK Company Information, Head Office, Market Area, and Industry Position
12.4.2 YSK Medical Grade Chitosan Models, Specifications, and Application
12.4.3 YSK Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 YSK Company Profile and Main Business
12.4.5 YSK Recent Developments
12.5 Vietnam Food
12.5.1 Vietnam Food Company Information, Head Office, Market Area, and Industry Position
12.5.2 Vietnam Food Medical Grade Chitosan Models, Specifications, and Application
12.5.3 Vietnam Food Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Vietnam Food Company Profile and Main Business
12.5.5 Vietnam Food Recent Developments
12.6 NovaMatrix
12.6.1 NovaMatrix Company Information, Head Office, Market Area, and Industry Position
12.6.2 NovaMatrix Medical Grade Chitosan Models, Specifications, and Application
12.6.3 NovaMatrix Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 NovaMatrix Company Profile and Main Business
12.6.5 NovaMatrix Recent Developments
12.7 KIMICA
12.7.1 KIMICA Company Information, Head Office, Market Area, and Industry Position
12.7.2 KIMICA Medical Grade Chitosan Models, Specifications, and Application
12.7.3 KIMICA Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 KIMICA Company Profile and Main Business
12.7.5 KIMICA Recent Developments
12.8 Heppe Medical Chitosan GmbH
12.8.1 Heppe Medical Chitosan GmbH Company Information, Head Office, Market Area, and Industry Position
12.8.2 Heppe Medical Chitosan GmbH Medical Grade Chitosan Models, Specifications, and Application
12.8.3 Heppe Medical Chitosan GmbH Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Heppe Medical Chitosan GmbH Company Profile and Main Business
12.8.5 Heppe Medical Chitosan GmbH Recent Developments
12.9 ChitoLytic
12.9.1 ChitoLytic Company Information, Head Office, Market Area, and Industry Position
12.9.2 ChitoLytic Medical Grade Chitosan Models, Specifications, and Application
12.9.3 ChitoLytic Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 ChitoLytic Company Profile and Main Business
12.9.5 ChitoLytic Recent Developments
12.10 Golden-Shell Pharmaceutical
12.10.1 Golden-Shell Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
12.10.2 Golden-Shell Pharmaceutical Medical Grade Chitosan Models, Specifications, and Application
12.10.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 Golden-Shell Pharmaceutical Company Profile and Main Business
12.10.5 Golden-Shell Pharmaceutical Recent Developments
12.11 Zhejiang Fengrun Biotech
12.11.1 Zhejiang Fengrun Biotech Company Information, Head Office, Market Area, and Industry Position
12.11.2 Zhejiang Fengrun Biotech Medical Grade Chitosan Models, Specifications, and Application
12.11.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Zhejiang Fengrun Biotech Company Profile and Main Business
12.11.5 Zhejiang Fengrun Biotech Recent Developments
12.12 Jiangsu Shuanglin
12.12.1 Jiangsu Shuanglin Company Information, Head Office, Market Area, and Industry Position
12.12.2 Jiangsu Shuanglin Medical Grade Chitosan Models, Specifications, and Application
12.12.3 Jiangsu Shuanglin Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Jiangsu Shuanglin Company Profile and Main Business
12.12.5 Jiangsu Shuanglin Recent Developments
12.13 Jiangsu Aoxin Biotechnology
12.13.1 Jiangsu Aoxin Biotechnology Company Information, Head Office, Market Area, and Industry Position
12.13.2 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Models, Specifications, and Application
12.13.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Jiangsu Aoxin Biotechnology Company Profile and Main Business
12.13.5 Jiangsu Aoxin Biotechnology Recent Developments
12.14 Qingdao Yunzhou Biochemistry
12.14.1 Qingdao Yunzhou Biochemistry Company Information, Head Office, Market Area, and Industry Position
12.14.2 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Models, Specifications, and Application
12.14.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Qingdao Yunzhou Biochemistry Company Profile and Main Business
12.14.5 Qingdao Yunzhou Biochemistry Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Medical Grade Chitosan should grow from US$ 68.34 million in 2024 to US$ 104 million by 2031, with a CAGR of 6.4% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Medical Grade Chitosan

According to YH Research, the global market for Medical Grade Chitosan should grow from US$ 68.34 million in 2024 to US$ 104 million by 2031, with a CAGR of 6.4% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In the current market, medical-grade chitosan refers to highly purified, specification-controlled chitosan that meets pharmaceutical or medical device expectations on bioburden, residuals, and defined structural parameters such as degree of deacetylation and molecular-weight distribution. As a cationic polysaccharide obtained by partial deacetylation of chitin, it offers hemostatic action, film-forming, and bioadhesion that make it valuable for wound care, emergency hemostats, drug delivery matrices, and tissue scaffolds. Suppliers differentiate by source—marine crustacean versus non-animal fungal origin—by form (powder, solutions, or salts/derivatives), and by quality systems (e.g., ISO 13485 and EU-GMP) that enable use in regulated settings. USP/NF defines chitosan and accepts DDA in a 70–95% window, anchoring analytical consistency for buyers and regulators.

Upstream, the key inputs are chitin from shrimp and crab shells or fungal biomass, caustic/alcohols for deacetylation, and purified water and cleanroom capacity for high-grade finishing. The midstream consists of specialized producers such as Heppe Medical Chitosan (ISO 13485; EU-GMP-aligned cleanroom production), Primex (ChitoCare Medical materials for wound and skin indications), and KitoZyme (fungal, non-animal origin), as well as Asian producers with medical-grade product lines. Downstream users include wound-care and emergency hemostat manufacturers with cleared devices, pharmaceutical companies using chitosan as an excipient or delivery aid, and research/clinical groups in tissue engineering and oral care. Procurement commonly blends long-term framework supply with quality-system audits and lot-release documentation; device OEMs often reference cleared indications via 510(k). Industry gross margins in this niche typically land around the mid-20s due to quality-system overhead, batch yields, documentation, and the premium for non-animal or ultrapure grades. Representative clearances and manufacturer quality statements illustrate these patterns.
In the current market, global production is around 650 t with an average selling price of about USD 64.27 per kg(EXW basis). Top suppliers together control roughly half to two-thirds of value, driven by qualification hurdles and brand trust in regulated applications; the supply landscape features marine-sourced leaders in Europe and Asia and a growing non-animal fungal segment in Europe. Demand is most visible in North America and Europe where cleared hemostats and wound products are widely used, with China and the broader Indo-Pacific ramping on both the supply and demand sides. Toward 2025–2031, the direction is steady expansion into drug-delivery adjuncts and tissue engineering, gradual mix-shift toward non-animal sources where regulatory or customer preferences require it, and continuing cost/quality optimization. Potential bottlenecks include variability in upstream chitin supply, the capital and documentation burden of ISO 13485/EU-GMP production, and device-side regulatory timelines that pace downstream offtake. Illustrative evidence includes USP/NF definitions, 510(k) device clearances, and supplier quality disclosures.

This report studies and analyses global Medical Grade Chitosan status and future trends, helps the client to determine the Medical Grade Chitosan market size of the total market opportunity by Source, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Medical Grade Chitosan, and provides market size (in Ton & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Medical Grade Chitosan market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Ton)
(2) Global Medical Grade Chitosan sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Ton)
(3) China Medical Grade Chitosan sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Ton)
(4) Global Medical Grade Chitosan key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Medical Grade Chitosan key producing regions, capacity, production, and year over year growth
(6) Medical Grade Chitosan industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Heppe Medical Chitosan GmbH
ChitoLytic
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry

Market segment by Source, covers
Marine (Crustacean-derived)
Fungal (Non-animal)

Market segment by Form, covers
Powder/Flake
Salts & Derivatives

Market segment by Channel, covers
Direct Sale
Indirect Sale

Market segment by Application, can be divided into
Wound Care & Exudate Management
Hemostats & Emergency Care
Pharma Excipients & Drug Delivery
Tissue Engineering & Regenerative Medicine
Medical Cosmetology
Other Medical Uses

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Medical Grade Chitosan product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Medical Grade Chitosan market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Medical Grade Chitosan market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Medical Grade Chitosan, percent & CAGR, 2020-2031
Chapter 5: Medical Grade Chitosan industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Source, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.